
Results
2
2 companies
argenx
Market Cap: €44.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€723.40
7D
0.9%
1Y
30.8%
Melexis
Market Cap: €2.3b
Designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle East, Africa, the Asia Pacific, and North and Latin America.
MELE
€57.85
7D
-11.0%
1Y
-2.1%